These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22018619)

  • 1. Rush allergen subcutaneous immunotherapy administered with infusion pump.
    Sastre J; Vallejo L; Hernández E; Fernández-Nieto M; Nieto PR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):459-60. PubMed ID: 22018619
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of rush subcutaneous immunotherapy administered in real life using an infusion pump.
    Uriarte Obando SA; Sastre Domínguez J
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):527-9. PubMed ID: 26460294
    [No Abstract]   [Full Text] [Related]  

  • 3. The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract.
    Roumana A; Pitsios C; Vartholomaios S; Kompoti E; Kontou-Fili K
    J Allergy Clin Immunol; 2009 Aug; 124(2):379-81. PubMed ID: 19560804
    [No Abstract]   [Full Text] [Related]  

  • 4. Bee pollen: a dangerous food for allergic children. Identification of responsible allergens.
    Martín-Muñoz MF; Bartolome B; Caminoa M; Bobolea I; Ara MC; Quirce S
    Allergol Immunopathol (Madr); 2010; 38(5):263-5. PubMed ID: 20447747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis caused by allergen sublingual immunotherapy?
    André C; Fadel R
    Allergy; 2007 Oct; 62(10):1220-1. PubMed ID: 17845597
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some highlights of the first century of immunotherapy.
    Nelson HS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612
    [No Abstract]   [Full Text] [Related]  

  • 8. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal immunotherapy in patients with allergic fungal sinusitis.
    Greenhaw B; deShazo RD; Arnold J; Wright L
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What will allergen immunotherapy look like in the future?
    Nelson HS
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):87-9. PubMed ID: 22840246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens.
    Pfaar O; Klimek L; Fischer I; Sieber J; Amoroso S; Moreno Aguilar C; Shah K; Mösges R
    Int Arch Allergy Immunol; 2009; 150(1):102-8. PubMed ID: 19339808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal complications due to desensitization].
    Drouet M; Sabbah A; Bonneau JC; Le Sellin J
    Allerg Immunol (Paris); 1986 Apr; 18(4):17-9. PubMed ID: 3453713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Allergy to bee and yellow jacket venoms].
    Saari S; Kalimo K; Viander M; Henriksson S
    Duodecim; 1985; 101(4):393-401. PubMed ID: 3979324
    [No Abstract]   [Full Text] [Related]  

  • 16. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of an Ultrarush (4 Hours) Subcutaneous Immunotherapy Schedule With Cat and Dog Extracts Using an Infusion Pump.
    Uriarte S; Sastre J
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):430-432. PubMed ID: 30530394
    [No Abstract]   [Full Text] [Related]  

  • 18. Rush injection therapy for asthma and allergic rhinitis.
    Greenberger PA
    Ann Allergy; 1994 Nov; 73(5):378-80. PubMed ID: 7978528
    [No Abstract]   [Full Text] [Related]  

  • 19. Local immunotherapy in chronic allergic rhinitis and bronchial asthma with allergen aerosols. III. Dynamics of some sensitization and immunity indexes.
    Moshkevich VS; Tsarevskaya LA; Nurpeisov TN; Nugmanova JS; Tsoy VP
    Allergol Immunopathol (Madr); 1986; 14(4):277-85. PubMed ID: 3776777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side-effects of allergen-specific immunotherapy: a prospective multi-centre study.
    Winther L; Arnved J; Malling HJ; Nolte H; Mosbech H
    Clin Exp Allergy; 2006 Mar; 36(3):254-60. PubMed ID: 16499635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.